Skip to main content
Fig. 6 | BMC Rheumatology

Fig. 6

From: Patient reported physical function, mental health, and treatment patterns in dermatomyositis: survey results from a cross-sectional study of adult dermatomyositis patients

Fig. 6

Medication Classes Taken by DM Patients. Among the 180 individuals that reported taking medication for DM, 72% (130/180) were taking immunosuppressants, 56% (101/180) were taking over the counter anti-inflammatory or pain medicines, 48% (86/180) were taking oral steroids, 36% (65/180) were taking topical steroids, 36% (65/180) were taking hydroxychloroquine, 32% (58/180) were taking immunoglobulin, 18% (32/180) were taking biologic, and 13% (23/180) were taking opioids. 23% (41/180) were also taking medications/supplements that were not listed (data not shown on graph)

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us